Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Singapore Medical Group stock

5OT.SI
SG1Y37945678

Price

0.40 SGD
Today +/-
+0 SGD
Today %
+0 %

Singapore Medical Group stock price

SGD
%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Singapore Medical Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Singapore Medical Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Singapore Medical Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Singapore Medical Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Singapore Medical Group Stock Price History

DateSingapore Medical Group Price
1/19/20230.40 SGD
1/18/20230.40 SGD

Singapore Medical Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Singapore Medical Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Singapore Medical Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Singapore Medical Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Singapore Medical Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Singapore Medical Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Singapore Medical Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Singapore Medical Group’s growth potential.

Singapore Medical Group Revenue, EBIT and net profit per share

DateSingapore Medical Group RevenueSingapore Medical Group EBITSingapore Medical Group Net Income
2025e141.35 M SGD25.15 M SGD35.87 M SGD
2024e132.15 M SGD22.71 M SGD24.36 M SGD
2023e117.16 M SGD18.89 M SGD16.71 M SGD
2022e112.11 M SGD17.47 M SGD15.73 M SGD
2021100.84 M SGD18.78 M SGD15.61 M SGD
202087.34 M SGD14.15 M SGD8.73 M SGD
201994.67 M SGD17.25 M SGD13.66 M SGD
201885.07 M SGD15.14 M SGD12.93 M SGD
201768 M SGD10.44 M SGD8.5 M SGD
201641.58 M SGD2.77 M SGD2.42 M SGD
201530.97 M SGD361,000 SGD-148,000 SGD
201426.51 M SGD-205,000 SGD79,000 SGD
201322.89 M SGD-3.83 M SGD-6.44 M SGD
201230.72 M SGD-550,000 SGD-1.57 M SGD
201131.32 M SGD-1.28 M SGD-1.13 M SGD
201034.85 M SGD3.3 M SGD2.34 M SGD
200931.99 M SGD2.26 M SGD1.55 M SGD
200830.12 M SGD6.23 M SGD5 M SGD
200724.65 M SGD9.91 M SGD8.15 M SGD
20064.28 M SGD1.63 M SGD1.29 M SGD

Singapore Medical Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M SGD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M SGD)NET INCOME (M SGD)NET INCOME GROWTH (%)DIV. (SGD)DIV. GROWTH (%)SHARES (M)DOCUMENTS
20062007200820092010201120122013201420152016201720182019202020212022e2023e2024e2025e
42430313431302226304168859487100112117132141
-500.0025.003.339.68-8.82-3.23-26.6718.1815.3836.6765.8525.0010.59-7.4514.9412.004.4612.826.82
75.0062.5056.6758.0655.8838.7136.6727.2730.7730.0034.1541.1843.5345.7443.6844.0039.2937.6133.3331.21
31517181912116891428374338440000
18512-1-1-60028121381515162435
-700.00-37.50-80.00100.00-150.00-500.00---300.0050.008.33-38.4687.50-6.6750.0045.83
--------------------
--------------------
142.94142.94142.94148.05154.31154.31154.31154.31224.23275.14287.7427.8472.42508.5482.84484.060000
--------------------
Details

Keystats

Revenue and Growth

The Singapore Medical Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Singapore Medical Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M SGD)RECEIVABLES (M SGD)OTHER REC. (M SGD)INVENTORIES (M SGD)OTHER CURRENT LIAB. (M SGD)CURRENT ASSETS (M SGD)TANGIBLE ASSETS (M SGD)LONG-T. INVEST. (M SGD)LONG-T. REC. (M SGD)INTANGIBLE ASSETS (M SGD)GOODWILL (M SGD)OTHER NON-CURRENT ASSETS (M SGD)NON-CURRENT ASSETS (M SGD)TOTAL ASSETS (M SGD)LIABILITIESCOMMON STOCK (M SGD)ADDITIONAL PAID-IN CAPITAL (M SGD)RETAINED EARNINGS (M SGD)OTHER EQUITY (M SGD)UNREAL. GAINS/LOSSES (M SGD)EQUITY (M SGD)LIABILITIES (M SGD)PROVISIONS (M SGD)OTHER SHORT-TERM LIAB. (M SGD)SHORT-TERM DEBTS (M SGD)LONG-TERM DEBT PORTION (M SGD)SHORT-TERM REC. (M SGD)LONG-T. LIAB. (M SGD)DEFERRED TAXES (k SGD)OTHER LIAB. (M SGD)LONG-T. LIABILITIES (M SGD)DEBT (M SGD)TOTAL CAPITAL (M SGD)
2006200720082009201020112012201320142015201620172018201920202021
                               
0.611.95.85.84.37.64.67.276.477.8221.3320.0127.3225.6226.62
1.22.70.90.10.10.70.70.60.831.363.464.756.035.635.275.97
00000.30.40.2-0.20.360.881.382.121.041.661.490.53
00.20.60.90.70.90.70.811.071.131.521.691.81.831.96
00.10.30.40.70.81.50.90.250.310.521.141.780.980.70.9
1.843.77.27.67.110.76.79.710.0914.330.8630.5537.3934.9135.97
1.533.73.94.94.74.332.242.637.3513.5113.6520.7516.6619.64
00000000.40.512.61.591.537.368.911.519.79
0.20.60.60.50.60.40.60.40.340.370.891.52.92.912.831.64
00000000009.5900.440.820.810.56
00000000000119.2126.1126.1123.1123.41
000000.10.40.20.430.50.721.040.840.750.730.83
1.73.64.34.45.55.25.343.516.120.14136.77151.3160.23155.63165.87
3.57.6811.613.112.31610.713.2116.1934.44167.63181.84197.62190.54201.84
                               
0.20.20.52.62.62.63315.2418.7129.2108.74118.92119.79119.84121.03
0000000000000000
1.20.40.31.82.70.7-0.9-7.2-8.33-8.36-5.89-0.3412.526.2533.2447.59
000000000-0.03-0.02-0.11-0.64-0.04-0.26-0.62
000000000000001.350
1.40.60.84.45.33.32.1-4.26.9110.3123.29108.28130.78145.99154.17168
0.20.61.91.31.11.11.31.51.791.31.841.911.652.121.892.08
0.21.71.51.71.71.71.71.20000008.729.41
0.74.13.13.22.32.221.40.882.364.8428.429.9417.768.338.69
000.10.10.61.921.80.51.010009.200
0.50.30.40.30.20.30.37.41.390.061.493.216.2211.5910.446.3
1.66.776.65.97.27.313.34.564.738.1733.5237.840.6729.3726.47
0.60.200.20.80.95.30.10.10.312.088.2711.711.096.997.89
01002001005002002002003157103170228259532
00000000.20.170.190.2717.411.840.380.410.41
0.60.30.20.31.31.15.50.50.30.52.3525.7813.7111.77.668.83
2.277.26.97.28.312.813.84.865.2310.5259.351.5252.3737.0335.3
3.67.6811.312.511.614.99.611.7715.5433.81167.58182.29198.36191.2203.3
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Singapore Medical Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Singapore Medical Group's financial health and stability.

Assets

Singapore Medical Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Singapore Medical Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Singapore Medical Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Singapore Medical Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M SGD)DEPRECIATION (M SGD)DEFERRED TAXES (M SGD)CHANGES IN WORKING CAPITAL (k SGD)NON-CASH ITEM (M SGD)PAID INTEREST (k SGD)PAID TAXES (M SGD)NET CASH FLOW FROM OPERATING ACTIVITIES (M SGD)CAPITAL EXPENDITURES (M SGD)CASH FLOW FROM INVESTING ACTIVITIES (M SGD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M SGD)INTEREST INCOME AND EXPENSES (M SGD)NET DEBT CHANGE (M SGD)NET CHANGE IN EQUITY (M SGD)CASH FLOW FROM FINANCING ACTIVITIES (M SGD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (SGD)TOTAL DIVIDENDS PAID (M SGD)NET CHANGE IN CASH FLOW (M SGD)FREE CASH FLOW (M SGD)SHARE-BASED COMPENSATION (M SGD)
2006200720082009201020112012201320142015201620172018201920202021
19623-10-6003914161018
0011211111123999
0000000000000000
01,00000-1,000-1,000000-1,00000-1,0000-1,000-1,000
000000030001112-1
00000000000001,0001,0000
0011100000000112
11173300-10041217262024
0-2-1-1-2000-1-1-1-5-3-2-1-4
0-2-1-1-20-1-10-3-2-22-28-18-3-9
000000000-2-1-17-25-16-1-5
0000000000000000
00000000000730-16-11
00020050430157000
0-9-41-10403202290-19-13
---------1.00-------1.00
0-9-40-1-100000000-1-1
00030-13-330113-17-10
0.589.565.812.180.79-1.36-0.5-1.99-0.8-1.163.417.7714.0223.9719.3420.24
0000000000000000

Singapore Medical Group stock margins

The Singapore Medical Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Singapore Medical Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Singapore Medical Group.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Singapore Medical Group's sales revenue. A higher gross margin percentage indicates that the Singapore Medical Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Singapore Medical Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Singapore Medical Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Singapore Medical Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Singapore Medical Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Singapore Medical Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Singapore Medical Group Margin History

Singapore Medical Group Gross marginSingapore Medical Group Profit marginSingapore Medical Group EBIT marginSingapore Medical Group Profit margin
2025e43.89 %17.79 %25.38 %
2024e43.89 %17.19 %18.43 %
2023e43.89 %16.12 %14.26 %
2022e43.89 %15.59 %14.03 %
202143.89 %18.62 %15.48 %
202043.55 %16.2 %10 %
201945.67 %18.22 %14.43 %
201844.43 %17.8 %15.2 %
201742.61 %15.35 %12.5 %
201635.85 %6.66 %5.83 %
201531.21 %1.17 %-0.48 %
201433.22 %-0.77 %0.3 %
201329.97 %-16.73 %-28.13 %
201237.11 %-1.79 %-5.11 %
201141.19 %-4.09 %-3.61 %
201055.9 %9.47 %6.71 %
200956.83 %7.06 %4.85 %
200859.5 %20.68 %16.6 %
200764.83 %40.2 %33.06 %
200682.71 %38.08 %30.14 %

Singapore Medical Group Stock Sales Revenue, EBIT, Earnings per Share

The Singapore Medical Group earnings per share therefore indicates how much revenue Singapore Medical Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Singapore Medical Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Singapore Medical Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Singapore Medical Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Singapore Medical Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Singapore Medical Group Revenue, EBIT and net profit per share

DateSingapore Medical Group Sales per ShareSingapore Medical Group EBIT per shareSingapore Medical Group Earnings per Share
2025e0.29 SGD0 SGD0.07 SGD
2024e0.27 SGD0 SGD0.05 SGD
2023e0.24 SGD0 SGD0.03 SGD
2022e0.23 SGD0 SGD0.03 SGD
20210.21 SGD0.04 SGD0.03 SGD
20200.18 SGD0.03 SGD0.02 SGD
20190.19 SGD0.03 SGD0.03 SGD
20180.18 SGD0.03 SGD0.03 SGD
20170.16 SGD0.02 SGD0.02 SGD
20160.14 SGD0.01 SGD0.01 SGD
20150.11 SGD0 SGD-0 SGD
20140.12 SGD-0 SGD0 SGD
20130.15 SGD-0.02 SGD-0.04 SGD
20120.2 SGD-0 SGD-0.01 SGD
20110.2 SGD-0.01 SGD-0.01 SGD
20100.23 SGD0.02 SGD0.02 SGD
20090.22 SGD0.02 SGD0.01 SGD
20080.21 SGD0.04 SGD0.03 SGD
20070.17 SGD0.07 SGD0.06 SGD
20060.03 SGD0.01 SGD0.01 SGD

Singapore Medical Group business model

The Singapore Medical Group Ltd is a leading company in the healthcare industry based in Singapore and with branches in various cities in Asia. The company's history dates back to 2005 when it was established as a small medical institute. Over the years, it has become one of the largest and most successful providers of healthcare services in Asia. SMG's business model is based on the vision of providing comprehensive healthcare services to all patients in one place. This includes general medicine as well as specialties such as cardiology, gastroenterology, oncology, orthopedics, and gynecology. Additionally, SMG also offers services such as diagnostics, imaging, rehabilitation, and wellness. SMG strives to provide its customers with the highest level of comfort and satisfaction. SMG has various divisions, including the Women and Children's clinic, the oncology department, the cardiology department, and the orthopedic department. In the Women and Children's clinic, the company offers a wide range of services such as prenatal care, obstetrics, gynecology, and pediatric care. The oncology department provides state-of-the-art diagnostic and treatment services for cancer patients. The cardiology department offers diagnostic and treatment services for heart diseases, while the orthopedic department offers diagnostic and treatment services for musculoskeletal disorders. SMG also offers a wide range of products, including medical devices, pharmaceuticals, and supplements. The company has many partnerships with leading manufacturers of medical devices and pharmaceuticals worldwide to provide its customers with the best products and services. Over the years, SMG has received numerous awards for its outstanding performance in the healthcare industry. Some of these awards include the Healthcare Asia Awards, the Global Health & Travel Awards, and the Singapore Health Quality Service Awards. The recognition for its work demonstrates SMG's commitment and success in the well-being of its patients. Overall, the history and success of SMG show that the company is a leading provider of healthcare services in Asia. With a comprehensive range of services and products focusing on the needs of patients, SMG has achieved a strong position in the market. SMG is committed to providing its customers with the highest level of comfort and satisfaction and is expected to continue growing and evolving in the years to come. Singapore Medical Group is one of the most popular companies on Eulerpool.com.

Singapore Medical Group SWOT Analysis

Strengths

Singapore Medical Group Ltd (SMG) possesses several strengths that contribute to its success in the medical industry:

  • Strong reputation: SMG is well-known for its high-quality healthcare services and has earned the trust of patients and partners.
  • Diverse range of medical specialties: SMG offers a comprehensive suite of medical services, covering various specialties, which enables it to cater to a wide range of healthcare needs.
  • Experienced and skilled healthcare professionals: SMG has a dedicated team of doctors and medical staff who are highly qualified and experienced, ensuring the delivery of excellent medical care.
  • Modern facilities and advanced technology: SMG continually invests in state-of-the-art equipment and facilities, keeping them at the forefront of medical advancements.

Weaknesses

Although Singapore Medical Group Ltd operates from a position of strength, it also faces certain weaknesses:

  • Limited geographical presence: SMG's operations are primarily centered in Singapore, which could restrict its growth potential compared to competitors with a broader international footprint.
  • Heavy reliance on key personnel: The success of SMG heavily relies on the expertise and leadership of its key personnel, making it vulnerable to potential talent retention challenges.
  • Higher cost structure: SMG's commitment to providing advanced medical facilities and services may lead to higher operating costs, which could impact its overall profitability.

Opportunities

Singapore Medical Group Ltd may leverage the following opportunities to further grow and expand its business:

  • Increasing demand for specialized medical services: As the demand for specialized healthcare services rises, SMG can capitalize on its diverse range of specialties to attract more patients.
  • Expansion into international markets: SMG can explore opportunities to expand its presence beyond Singapore, targeting markets with a growing demand for quality healthcare.
  • Strategic partnerships and collaborations: Collaborating with other healthcare providers, medical institutions, or technology companies can enhance SMG's capabilities and reach.

Threats

Despite its strengths and opportunities, Singapore Medical Group Ltd should be aware of potential threats that could impact its operations:

  • Intense competition: The medical industry is highly competitive, with the presence of both established players and emerging startups. SMG must stay innovative and differentiate itself to maintain market share.
  • Regulatory challenges: Evolving regulations and compliance requirements could pose challenges for SMG, necessitating constant adaptation and ensuring compliance with changing healthcare standards.
  • Economic uncertainties: Economic downturns or changes in healthcare policies and funding may affect patients' spending capacity and demand for medical services.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Singapore Medical Group Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Singapore Medical Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Singapore Medical Group shares outstanding

The number of shares was Singapore Medical Group in 2023 — This indicates how many shares 484.059 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Singapore Medical Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Singapore Medical Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Singapore Medical Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Singapore Medical Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Singapore Medical Group dividend history and estimates

In 2023, Singapore Medical Group paid a dividend amounting to 0.01 SGD. Dividend means that Singapore Medical Group distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Singapore Medical Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Singapore Medical Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Singapore Medical Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Singapore Medical Group Dividend History

DateSingapore Medical Group Dividend
2025e0.01 SGD
2024e0.01 SGD
2023e0.01 SGD
2022e0.01 SGD
20210 SGD
20200 SGD
20110.01 SGD
20100.01 SGD

Singapore Medical Group dividend payout ratio

In 2023, Singapore Medical Group had a payout ratio of 17.27%. The payout ratio indicates the percentage of the company's profits that Singapore Medical Group distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Singapore Medical Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Singapore Medical Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Singapore Medical Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Singapore Medical Group Payout Ratio History

DateSingapore Medical Group Payout ratio
2025e16.73 %
2024e15.65 %
2023e17.27 %
2022e17.27 %
202112.41 %
202022.12 %
201917.27 %
201817.28 %
201717.31 %
201617.41 %
201517.69 %
201418.53 %
201321.07 %
201228.67 %
2011-77.44 %
201051.47 %
200928.67 %
200828.67 %
200728.67 %
200628.67 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Singapore Medical Group.

Singapore Medical Group shareholders

%
Name
Stocks
Change
Date
23.83839 % CHA Healthcare Singapore Pte. Ltd.116,000,00003/31/2022
7.46143 % Tan (Choon Keat Tony)36,308,07303/31/2022
6.91032 % Beng (Teck Liang)33,626,32903/31/2022
5.61566 % Red Ancient Global Ltd27,326,34803/31/2022
2.23359 % Wong (Seng Weng)10,868,85303/31/2022
1.88079 % Cheng (Yong Liang)9,152,1211,364,8523/31/2022
1.06663 % Low (Chai Ling)5,190,3125,190,3123/31/2022
0.82103 % IFast Financial Pte Ltd.3,995,2251,146,8003/31/2022
0.76036 % Low (Hwee Theng)3,700,00003/31/2022
0.62679 % Asdew Acquisitions Pte. Ltd.3,050,0001,000,0003/31/2022
1
2

Most common questions regarding Singapore Medical Group

What values and corporate philosophy does Singapore Medical Group represent?

Singapore Medical Group Ltd represents values of excellence, innovation, and compassion in the healthcare industry. Committed to delivering quality medical services, the company focuses on patient-centric care and exceptional outcomes. With a strong corporate philosophy, Singapore Medical Group Ltd emphasizes professionalism, integrity, and a patient-first approach. It continuously strives to stay at the forefront of medical advancements, providing cutting-edge technologies and evidence-based treatments. By integrating expertise across multiple medical specialties, Singapore Medical Group Ltd aims to enhance the overall healthcare experience for its patients. Through collaboration, continuous improvement, and a commitment to ethical practices, the company seeks to establish itself as a trusted and reliable healthcare provider in Singapore and beyond.

In which countries and regions is Singapore Medical Group primarily present?

Singapore Medical Group Ltd is primarily present in Singapore, where its headquarters are located. As a leading integrated healthcare provider, the company serves patients across various medical specialties such as women's health, oncology, orthopedics, dermatology, and more. With a strong presence in Singapore's healthcare scene, Singapore Medical Group Ltd offers comprehensive healthcare solutions and personalized services to meet the diverse needs of patients.

What significant milestones has the company Singapore Medical Group achieved?

Singapore Medical Group Ltd has achieved several significant milestones. Firstly, the company expanded its presence by acquiring various medical and dental clinics, strengthening its market position. Additionally, Singapore Medical Group successfully listed on the Catalist board of the Singapore Exchange Securities Trading Limited (SGX-ST), enhancing its credibility and accessibility to investors. Furthermore, the company has consistently demonstrated strong financial performance, with steady revenue growth year after year. Singapore Medical Group has also received multiple accolades, including being listed on the Forbes Asia's "Best Under A Billion" list. These milestones reflect the company's commitment to delivering comprehensive and high-quality healthcare services, solidifying its position as a leading player in the industry.

What is the history and background of the company Singapore Medical Group?

Singapore Medical Group Ltd (SMG) is a leading medical specialist and private healthcare provider in Singapore. Established in 2005, SMG offers a comprehensive range of healthcare services across various disciplines, including obstetrics and gynecology, orthopedics, dermatology, ophthalmology, and more. The company has a rich history of providing exceptional clinical expertise and personalized care to patients. With a strong track record and a commitment to quality healthcare, SMG has emerged as a trusted name in the medical industry. Today, Singapore Medical Group Ltd continues to expand its network of clinics and medical facilities, ensuring accessible and superior healthcare services for all.

Who are the main competitors of Singapore Medical Group in the market?

The main competitors of Singapore Medical Group Ltd in the market include Raffles Medical Group, IHH Healthcare Berhad, and I-Medical Group.

In which industries is Singapore Medical Group primarily active?

Singapore Medical Group Ltd (SMG) primarily operates in the healthcare industry. With a focus on providing specialized medical services, SMG offers a wide range of healthcare solutions to cater to various medical needs. The company's expertise extends across multiple disciplines, including but not limited to women's health, aesthetics, dermatology, ophthalmology, and general medicine. SMG's commitment to delivering excellent patient care and its comprehensive range of medical services have positioned the company as a prominent player in the healthcare industry.

What is the business model of Singapore Medical Group?

Singapore Medical Group Ltd is a leading medical services provider in Singapore. The company's business model focuses on offering a comprehensive range of healthcare services, including primary care, specialty care, and medispa services. Singapore Medical Group Ltd operates through a multi-disciplinary approach, providing patients with integrated healthcare solutions for different medical needs. By leveraging its extensive network of medical professionals, the company ensures the delivery of high-quality and personalized care to its patients. With a patient-centric approach and a commitment to excellence, Singapore Medical Group Ltd continues to be a trusted name in the healthcare industry.

What is the P/E ratio of Singapore Medical Group 2024?

The Singapore Medical Group P/E ratio is 7.85.

What is the P/S ratio of Singapore Medical Group 2024?

The Singapore Medical Group P/S ratio is 1.45.

What is the Quality Investing of Singapore Medical Group?

The Quality Investing for Singapore Medical Group is 5/10.

What is the revenue of Singapore Medical Group 2024?

The expected Singapore Medical Group revenue is 132.15 M SGD.

How high is the profit of Singapore Medical Group 2024?

The expected Singapore Medical Group profit is 24.36 M SGD.

What is the business model of Singapore Medical Group

The Singapore Medical Group Ltd (SMG) is a leading provider of integrated medical services in Singapore. The company offers a wide range of medical services and products to promote health and well-being. SMG's business model is focused on diversifying its services, which are delivered in five main areas: Obstetrics and Gynecology, Pediatrics, Cancer Treatment, Dentistry, and General Medicine. The Obstetrics and Gynecology segment specializes in supporting women during pregnancy, childbirth, and beyond. The offerings range from prenatal examinations and childbirth preparation courses to gynecology and menopause counseling. In Pediatrics, SMG provides medical care to children of all ages, from premature and newborns to teenagers. The care includes vaccinations, preventive check-ups, as well as diagnosis and treatment of diseases. In the field of cancer treatment, SMG offers a comprehensive range of services, including diagnosis and treatment of cancer at all stages. The company utilizes advanced technologies and therapies to ensure optimal care for its patients. SMG's dentistry services include various areas such as prosthodontics, orthodontics, endodontics, and periodontics. The aim is to provide comprehensive dental care to patients in all areas of dentistry. In general medicine, SMG strives to provide ongoing medical care for patients of all age groups. This includes check-ups, prevention, diagnostics, and treatment of various diseases. SMG also offers its patients a wide range of medical products, including dietary supplements, vitamins, and other health products, to promote their health. SMG adopts a holistic approach to ensure that patient treatment is not only based on medical needs but also tailored to their overall well-being. The company aims to meet the individual needs and requirements of its patients by offering a wide range of services and products. In summary, SMG's business model is focused on comprehensive medical care in various areas of medicine. By diversifying its services and products, the company provides its patients with a wide range of options and secures its long-term success.

What is the Singapore Medical Group dividend?

Singapore Medical Group pays a dividend of 0.01 SGD distributed over payouts per year.

How often does Singapore Medical Group pay dividends?

The dividend cannot currently be calculated for Singapore Medical Group or the company does not pay out a dividend.

What is the Singapore Medical Group ISIN?

The ISIN of Singapore Medical Group is SG1Y37945678.

What is the Singapore Medical Group ticker?

The ticker of Singapore Medical Group is 5OT.SI.

How much dividend does Singapore Medical Group pay?

Over the past 12 months, Singapore Medical Group paid a dividend of 0 SGD . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Singapore Medical Group is expected to pay a dividend of 0.01 SGD.

What is the dividend yield of Singapore Medical Group?

The current dividend yield of Singapore Medical Group is 1.01 %.

When does Singapore Medical Group pay dividends?

Singapore Medical Group pays a quarterly dividend. This is distributed in the months of May, July, June, June.

How secure is the dividend of Singapore Medical Group?

Singapore Medical Group paid dividends every year for the past 6 years.

What is the dividend of Singapore Medical Group?

For the upcoming 12 months, dividends amounting to 0.01 SGD are expected. This corresponds to a dividend yield of 3.12 %.

In which sector is Singapore Medical Group located?

Singapore Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Singapore Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Singapore Medical Group from 5/13/2022 amounting to 0.009 SGD, you needed to have the stock in your portfolio before the ex-date on 5/4/2022.

When did Singapore Medical Group pay the last dividend?

The last dividend was paid out on 5/13/2022.

What was the dividend of Singapore Medical Group in the year 2023?

In the year 2023, Singapore Medical Group distributed 0.009 SGD as dividends.

In which currency does Singapore Medical Group pay out the dividend?

The dividends of Singapore Medical Group are distributed in SGD.

All fundamentals about Singapore Medical Group

Our stock analysis for Singapore Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Singapore Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.